vs
CSW INDUSTRIALS, INC.（CSW）与IONIS PHARMACEUTICALS INC（IONS）财务数据对比。点击上方公司名可切换其他公司
CSW INDUSTRIALS, INC.的季度营收约是IONIS PHARMACEUTICALS INC的1.1倍（$233.0M vs $203.3M），CSW INDUSTRIALS, INC.净利率更高（4.4% vs -112.8%，领先117.2%），CSW INDUSTRIALS, INC.同比增速更快（20.3% vs -10.3%），CSW INDUSTRIALS, INC.自由现金流更多（$22.7M vs $-159.0M），过去两年IONIS PHARMACEUTICALS INC的营收复合增速更高（30.4% vs 5.1%）
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
CSW vs IONS — 直观对比
营收规模更大
CSW
是对方的1.1倍
$203.3M
营收增速更快
CSW
高出30.6%
-10.3%
净利率更高
CSW
高出117.2%
-112.8%
自由现金流更多
CSW
多$181.7M
$-159.0M
两年增速更快
IONS
近两年复合增速
5.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $233.0M | $203.3M |
| 净利润 | $10.3M | $-229.4M |
| 毛利率 | 39.7% | 96.1% |
| 营业利润率 | 7.4% | -105.5% |
| 净利率 | 4.4% | -112.8% |
| 营收同比 | 20.3% | -10.3% |
| 净利润同比 | -61.9% | -119.8% |
| 每股收益（稀释后） | $0.62 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSWIONS
| Q4 25 | $233.0M | $203.3M | ||
| Q3 25 | $277.0M | $156.7M | ||
| Q2 25 | $263.6M | $452.0M | ||
| Q1 25 | $230.5M | $131.6M | ||
| Q4 24 | $193.6M | $226.6M | ||
| Q3 24 | $227.9M | $133.8M | ||
| Q2 24 | $226.2M | $225.3M | ||
| Q1 24 | $210.9M | $119.5M |
净利润CSWIONS
| Q4 25 | $10.3M | $-229.4M | ||
| Q3 25 | $40.7M | $-128.6M | ||
| Q2 25 | $40.9M | $123.6M | ||
| Q1 25 | $35.1M | $-146.9M | ||
| Q4 24 | $26.9M | $-104.3M | ||
| Q3 24 | $36.1M | $-140.5M | ||
| Q2 24 | $38.6M | $-66.3M | ||
| Q1 24 | $31.8M | $-142.8M |
毛利率CSWIONS
| Q4 25 | 39.7% | 96.1% | ||
| Q3 25 | 43.0% | 98.5% | ||
| Q2 25 | 43.8% | 99.1% | ||
| Q1 25 | 44.2% | 98.9% | ||
| Q4 24 | 41.4% | 98.3% | ||
| Q3 24 | 45.6% | 99.2% | ||
| Q2 24 | 47.5% | 98.2% | ||
| Q1 24 | 44.4% | 98.2% |
营业利润率CSWIONS
| Q4 25 | 7.4% | -105.5% | ||
| Q3 25 | 20.5% | -102.2% | ||
| Q2 25 | 20.8% | 30.9% | ||
| Q1 25 | 19.5% | -111.6% | ||
| Q4 24 | 15.3% | -48.9% | ||
| Q3 24 | 22.6% | -111.1% | ||
| Q2 24 | 24.3% | -29.3% | ||
| Q1 24 | 21.0% | -125.1% |
净利率CSWIONS
| Q4 25 | 4.4% | -112.8% | ||
| Q3 25 | 14.7% | -82.1% | ||
| Q2 25 | 15.5% | 27.3% | ||
| Q1 25 | 15.2% | -111.6% | ||
| Q4 24 | 13.9% | -46.1% | ||
| Q3 24 | 15.8% | -105.0% | ||
| Q2 24 | 17.1% | -29.4% | ||
| Q1 24 | 15.1% | -119.5% |
每股收益（稀释后）CSWIONS
| Q4 25 | $0.62 | $-1.35 | ||
| Q3 25 | $2.41 | $-0.80 | ||
| Q2 25 | $2.43 | $0.70 | ||
| Q1 25 | $2.05 | $-0.93 | ||
| Q4 24 | $1.60 | $-0.66 | ||
| Q3 24 | $2.26 | $-0.95 | ||
| Q2 24 | $2.47 | $-0.45 | ||
| Q1 24 | $2.03 | $-0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.2M | $2.7B |
| 总债务越低越好 | — | $1.8B |
| 股东权益账面价值 | $1.1B | $489.1M |
| 总资产 | $2.3B | $3.5B |
| 负债/权益比越低杠杆越低 | — | 3.71× |
8季度趋势，按日历期对齐
现金及短期投资CSWIONS
| Q4 25 | $40.2M | $2.7B | ||
| Q3 25 | $31.5M | $2.2B | ||
| Q2 25 | $38.0M | $2.3B | ||
| Q1 25 | $225.8M | $2.1B | ||
| Q4 24 | $213.8M | $2.3B | ||
| Q3 24 | $273.2M | $2.5B | ||
| Q2 24 | $18.9M | $2.1B | ||
| Q1 24 | $22.2M | $2.2B |
总债务CSWIONS
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $800.1M | — | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | — |
股东权益CSWIONS
| Q4 25 | $1.1B | $489.1M | ||
| Q3 25 | $1.1B | $618.0M | ||
| Q2 25 | $1.1B | $631.7M | ||
| Q1 25 | $1.1B | $475.7M | ||
| Q4 24 | $1.0B | $588.4M | ||
| Q3 24 | $1.0B | $662.5M | ||
| Q2 24 | $650.2M | $263.7M | ||
| Q1 24 | $615.7M | $296.5M |
总资产CSWIONS
| Q4 25 | $2.3B | $3.5B | ||
| Q3 25 | $1.5B | $3.0B | ||
| Q2 25 | $1.5B | $3.0B | ||
| Q1 25 | $1.4B | $2.8B | ||
| Q4 24 | $1.4B | $3.0B | ||
| Q3 24 | $1.4B | $3.1B | ||
| Q2 24 | $1.1B | $2.7B | ||
| Q1 24 | $1.0B | $2.8B |
负债/权益比CSWIONS
| Q4 25 | — | 3.71× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | — | 2.13× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.9M | $-137.7M |
| 自由现金流经营现金流 - 资本支出 | $22.7M | $-159.0M |
| 自由现金流率自由现金流/营收 | 9.8% | -78.2% |
| 资本支出强度资本支出/营收 | 2.6% | 10.5% |
| 现金转化率经营现金流/净利润 | 2.81× | — |
| 过去12个月自由现金流最近4个季度 | $162.0M | $-320.0M |
8季度趋势，按日历期对齐
经营现金流CSWIONS
| Q4 25 | $28.9M | $-137.7M | ||
| Q3 25 | $61.8M | $-131.4M | ||
| Q2 25 | $60.6M | $151.3M | ||
| Q1 25 | $27.3M | $-150.8M | ||
| Q4 24 | $11.6M | $-116.1M | ||
| Q3 24 | $66.8M | $-115.0M | ||
| Q2 24 | $62.7M | $-119.9M | ||
| Q1 24 | $22.4M | $-149.9M |
自由现金流CSWIONS
| Q4 25 | $22.7M | $-159.0M | ||
| Q3 25 | $58.7M | $-136.7M | ||
| Q2 25 | $57.7M | $139.0M | ||
| Q1 25 | $22.8M | $-163.4M | ||
| Q4 24 | $8.5M | $-141.6M | ||
| Q3 24 | $61.3M | $-124.0M | ||
| Q2 24 | $59.6M | $-126.1M | ||
| Q1 24 | $17.5M | $-154.4M |
自由现金流率CSWIONS
| Q4 25 | 9.8% | -78.2% | ||
| Q3 25 | 21.2% | -87.2% | ||
| Q2 25 | 21.9% | 30.8% | ||
| Q1 25 | 9.9% | -124.1% | ||
| Q4 24 | 4.4% | -62.5% | ||
| Q3 24 | 26.9% | -92.7% | ||
| Q2 24 | 26.3% | -56.0% | ||
| Q1 24 | 8.3% | -129.2% |
资本支出强度CSWIONS
| Q4 25 | 2.6% | 10.5% | ||
| Q3 25 | 1.1% | 3.4% | ||
| Q2 25 | 1.1% | 2.7% | ||
| Q1 25 | 2.0% | 9.6% | ||
| Q4 24 | 1.6% | 11.3% | ||
| Q3 24 | 2.4% | 6.8% | ||
| Q2 24 | 1.4% | 2.8% | ||
| Q1 24 | 2.3% | 3.8% |
现金转化率CSWIONS
| Q4 25 | 2.81× | — | ||
| Q3 25 | 1.52× | — | ||
| Q2 25 | 1.48× | 1.22× | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 0.71× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
